iiinova — where your digital self keeps evolving

Reposted by Cris Bergerot, PhD

ASCO Palliative Oncology Community of Practice (PallOncCoP) @pallonccop.bsky.social · 27/09/2026

🔊Join the growing global ASCO PallOnc COP as we kick off the year nurturing old and new connections while gearing up for another successful year. DM for the zoom meeting link and to join our listserv. 🕒We can't wait to greet you all on Sep 29, 2026 @ 16:00 EST.

143

Reposted by Cris Bergerot, PhD

International Society of Geriatric Oncology (SIOG) @siogorg.bsky.social · 17/09/2026

Still deciding on SIOG 2026? SIOG members pay a lower registration rate. Joining before you register can bring the cost down and gives you access to the community year-round. 5–7 Nov, Valencia. loom.ly/ITKRCJQ #SIOG2026 #GeriOnc #CancerCare

011

Reposted by Cris Bergerot, PhD

EORTC Quality of Life Group (QLG) @qol.eortc.org · 17/09/2026

📰 The 2026 @eortc.org #QualityofLife Group (QLG) newsletter has arrived! Catch up on the latest QLG research and initiatives, including perspectives on the opportunities and challenges of AI in quality of life research. 🔗 qol.eortc.org/newsletters/ #GivingVoice2Patients #CancerResearch

011

Reposted by Cris Bergerot, PhD

JCO Journals @jco-asco.bsky.social · 17/09/2026

Advance the science of oncology. As a JCO Journals reviewer, you can sharpen your own research skills while protecting the quality of cancer research. Earn CME credits and FASCO™ points. Learn more and become a reviewer today: bit.ly/3VvklTa #PeerReviewWeek

011

Reposted by Cris Bergerot, PhD

Conquer Cancer, the ASCO Foundation @conquercancer.bsky.social · 08/09/2026

Cancer's impact knows no borders. Conquer Cancer has supported researchers in over 102 countries—representing about 52% of countries worldwide. Learn more at conquer.org.

011

Reposted by Cris Bergerot, PhD

JCO Journals @jco-asco.bsky.social · 08/09/2026

Could biomarker selection broaden immunotherapy’s role in pancreatic cancer? A phase II trial evaluates cemiplimab + gemcitabine in metastatic #PDAC with SWI/SNF alterations. @bottalab.bsky.social @shawnabeynaike.bsky.social Read the article. bit.ly/4xS8V9V

011

Reposted by Cris Bergerot, PhD

American Society of Clinical Oncology @ascocancer.bsky.social · 03/09/2026

Thank you ASCO member Dr. @fumikochino.bsky.social for speaking on the importance of federal cancer research funding! #ASCOAdvocacy continues to urge Congress to pass a full, bipartisan FY27 bill to provide the strongest possible investments in medical research.

youtube.com

The Battle for Cancer Research Funding: What You Need to Know

YouTube video by Money Matters Podcast | HFFG

042

Reposted by Cris Bergerot, PhD

American Society of Clinical Oncology @ascocancer.bsky.social · 01/09/2026

What’s the optimal follow-up visit schedule for patients with #breastcancer? The latest ASCO guideline update recommends a risk-based approach. See the highlights in #ASCODailyNews: bit.ly/4xwJoUh

031

Reposted by Cris Bergerot, PhD

International Society of Geriatric Oncology (SIOG) @siogorg.bsky.social · 21/07/2026

The add-on sessions at SIOG 2026 are how the conference gets off to a strong start. Five sessions on 5 November, pre-registration required and several run in parallel. Early bird open until 8 September. loom.ly/LBPOUSE #SIOG2026 #GeriOnc

011

Reposted by Cris Bergerot, PhD

International Society of Geriatric Oncology (SIOG) @siogorg.bsky.social · 29/07/2026

What does bringing geriatric assessment into routine practice actually look like? This #SIOGwebinar on 5 August at 15:00 CEST has two clinicians sharing their experiences. Free, open to all. Register: loom.ly/svYTJsA #GeriatricOncology #GeriOnc

022

Reposted by Cris Bergerot, PhD

International Society of Geriatric Oncology (SIOG) @siogorg.bsky.social · 05/08/2026

We are live today at 15:00 CEST. Geriatric assessment in routine cancer care. Free to join. Register: loom.ly/svYTJsA #GeriatricOncology #GeriOnc

011

Reposted by Cris Bergerot, PhD

International Society of Geriatric Oncology (SIOG) @siogorg.bsky.social · 12/08/2026

Missed it live? The SIOG Webinar on geriatric assessment in routine cancer care is now on demand. loom.ly/QX6EvEA #GeriatricOncology #GeriOnc

022

Reposted by Cris Bergerot, PhD

JCO Journals @jco-asco.bsky.social · 02/09/2026

ASCO is pleased to name Thomas E. Stinchcombe, MD, FASCO from @dukecancer.bsky.social as the new Editor-in-Chief of JCO, beginning January 2027. Dr. Stinchcombe’s expertise will drive innovation, faster publication timelines, and expanded global reach for high-impact cancer research.

032

Reposted by Cris Bergerot, PhD

Journal of the American Geriatrics Society (JAGS) @agsjournal.bsky.social · 31/08/2026

A telehealth geriatric assessment and management intervention increased approach-oriented coping among older adults with metastatic cancer. agsjournals.onlinelibrary.wiley.com…

022

Reposted by Cris Bergerot, PhD

International Psycho-Oncology Society (IPOS) @ipospsychooncol.bsky.social · 17/08/2026

⏳ TIME IS RUNNING OUT! The IPOS Delphi Study on global psycho-oncology competencies closes August 21. Don't let international clinical standards be set without your expertise! Shape the future here: hku.au1.qualtrics.com/jfe/form/SV_...

011

Reposted by Cris Bergerot, PhD

JCO Journals @jco-asco.bsky.social · 18/08/2026

Can treatment for intermediate-risk #Rhabdomyosarcoma be refined to improve local control while reducing long-term toxicity? Read the article: bit.ly/4q7tOvp

011

Reposted by Cris Bergerot, PhD

KidneyCAN @kidneycan.bsky.social · 03/07/2026

There’s no wrong way to experience #KCRS26, just the way that works best for you. However you attend, you'll be part of the community working to accelerate progress in #KidneyCancer research. Register today: bit.ly/KCRS26Registration #AcceleratingCures

021

Cris Bergerot, PhD @crisbergerot.bsky.social · 03/07/2026

People with SMI face inequities in cancer care and survival Equitable oncology requires integrated psychiatric care and system-level change @cacancerjournal.bsky.social #McFarland @kellyirwin25.bsky.social acsjournals.onlinelibrary.wiley.com/doi/10.3322/...

022

Reposted by Cris Bergerot, PhD

Dr Alison B @aliblipcdoc.bsky.social · 25/06/2026

As a rural practitioner I thank Prof Anna Ugalde for the work she + team @deakinuniversity.bsky.social does on supportive care & bringing equitable cancer outcomes in rural and remote communities closer to reality. #MASCC26 @cancercaremascc.bsky.social @markbutlermp.bsky.social @theracp.bsky.social

042

Reposted by Cris Bergerot, PhD

Darcy Burbage, DNP, RN, AOCN @darcyburbage.bsky.social · 15/06/2026

Excited to be selected as a social media ambassador for #MASCC26! Looking forward to sharing the latest research in supportive care alongside my amazing colleagues from across the globe! Follow along! @cancercaremascc.bsky.social

031

Reposted by Cris Bergerot, PhD

Darcy Burbage, DNP, RN, AOCN @darcyburbage.bsky.social · 24/06/2026

👥 Registration opens at 3pm today for @cancercaremascc.bsky.social #MASCC26! 🩺 Can’t wait to see and learn alongside my colleagues & present on survivorship with @michael-jefford.bsky.social & #DrLarissaNekhlyudov! 🇦🇺 See you soon!

022

Reposted by Cris Bergerot, PhD

Journal of the American Geriatrics Society (JAGS) @agsjournal.bsky.social · 25/06/2026

Loneliness interventions: Categories, examples, and end-of-life modifications. #geriatrics agsjournals.onlinelibrary.wiley.com…

131

Reposted by Cris Bergerot, PhD

American Society of Clinical Oncology @ascocancer.bsky.social · 12/06/2026

Our new position statement outlines ways to expand eligibility, increase funding & expand community access for pediatric oncology clinical trials. Learn more: bit.ly/4v1q7J7 #ASCOAdvocacy

033

Reposted by Cris Bergerot, PhD

International Psycho-Oncology Society (IPOS) @ipospsychooncol.bsky.social · 02/06/2026

Less than 2 weeks to go! Webinar: High Risk of Fear of Cancer Recurrence June 15, 2026, 1 to 2 p.m. EDT Live Webcast FEATURING: 1. Lauren Rudy 2. Prof. Dr. Marije van der Lee 3. Dr. Sophie Lebel For more information and to register ipos-society.org/event-6683185

021

Reposted by Cris Bergerot, PhD

American Society of Clinical Oncology @ascocancer.bsky.social · 02/06/2026

🎙 It's the final daily episode of #ASCO26! Dr. Monty Pal of @cityofhope.bsky.social provides his Top Takeaways on key Day 5 abstracts, available now on the #ASCODailyNews Podcast: bit.ly/3Rv9wPj

031

Reposted by Cris Bergerot, PhD

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 02/06/2026

Heading home from #ASCO26 today! Put two dates for @ascocancer.bsky.social Quality Care Symposium on your calendar: 🚨Abstracts are due in 2 weeks 6/16/2026 📆 #ASCOQLTY26 is Friday-Saturday 10/16-17/2026 See you in Boston! www.asco.org/quality

A woman with glasses and a mask in front of a large sign advertising ASCO ACS with the dates 10/16-10/17

064

Reposted by Cris Bergerot, PhD

American Society of Clinical Oncology @ascocancer.bsky.social · 01/06/2026

Don’t miss our joint session w/ American Society of Preventive Oncology chaired by Dr Kimmie Ng of @danafarber.bsky.social & Dr Irene Su w panelists @crisbergerot.bsky.social & Dr. Tara Henderson of @luriechildrens.bsky.social on rising incidence of young adults w cancer. bit.ly/4e4idHY

041

Reposted by Cris Bergerot, PhD

American Society of Clinical Oncology @ascocancer.bsky.social · 31/05/2026

The final study presented at #ASCO26 Plenary: RASolute-302 results show daraxonrasib meeting all primary and key secondary endpoints, demonstrating significant and clinically meaningful improvements in OS, PFS, and ORR in metastatic #PDAC: bit.ly/49r62n1 #ASCODailyNews

0145

Reposted by Cris Bergerot, PhD

International Kidney Cancer Coalition @ikccorg.bsky.social · 27/04/2026

IKCC and the Global Cancer Coalitions Network are convening at IARC-WHO in Lyon, France for the GCCN Annual Meeting 2026. Representatives from global patient association networks are collaborating to address the challenges faced by patient organisations and to establish shared goals for 2030.

031

Reposted by Cris Bergerot, PhD

The Hope Foundation for Cancer Research @supportingswog.bsky.social · 27/04/2026

Apply by May 1: All #NCTN group members are eligible! @swog.org Virtual Grant Writing Workshop #SWOGonc conta.cc/3Qqnm4M

022

Reposted by Cris Bergerot, PhD

International Psycho-Oncology Society (IPOS) @ipospsychooncol.bsky.social · 27/04/2026

Webinar: Expert Session FORWard Interest Group Featuring Ben Smith (Australia) — May 18, 2026 Dr. Ben Smith has a particular interest in fear of cancer recurrence, digital health interventions and underserved populations impacted by cancer. Read more ipos-society.org/event-6673842

031

Reposted by Cris Bergerot, PhD

International Kidney Cancer Coalition @ikccorg.bsky.social · 20/04/2026

World Kidney Cancer Day is just around the corner—less than two months to go! 💙 Mark your calendars for 18 June 2026, and join us as we shine a light on this year’s important theme: Kidney Cancer and Emotional Wellbeing. Find out more: ikcc.org/world-kidney... #WorldKidneyCancerDay #WKCD

021

Reposted by Cris Bergerot, PhD

The ASCO Post @ascopost.bsky.social · 21/04/2026

Managing advanced RCC after adjuvant immunotherapy In this roundtable discussion, experts explore treatment strategies for patients with disease progression following adjuvant pembrolizumab. 🎥 : ow.ly/o2FW50YLe9Q

011

Reposted by Cris Bergerot, PhD

American Society of Clinical Oncology @ascocancer.bsky.social · 21/04/2026

Abstract titles for #ASCO26 are now available! Get a first look at the science that will be presented and be a part of the conversation. Browse the titles and start planning your experience: bit.ly/4cecv6w If you haven’t yet registered, early reg ends tomorrow!

042

Reposted by Cris Bergerot, PhD

The ASCO Post @ascopost.bsky.social · 22/04/2026

Updated NCCN guidance recommends starting breast cancer screening at age 35 for women identified as high-risk through AI models or other validated risk assessment tools. ➡️ This signals a broader move toward data-driven, individualized screening pathways. ow.ly/WFjY50YLecm

ow.ly

NCCN Guidelines Update Recommends Breast Cancer Screening at Age 35 for High-Risk Women Identified by AI

011

Reposted by Cris Bergerot, PhD

American Society of Clinical Oncology @ascocancer.bsky.social · 22/04/2026

Elevate the quality, safety & efficiency of cancer care delivery—submit your research to #ASCOQLTY26. By presenting findings, you’re shaping a vibrant community of professionals dedicated to advancing patient care. Prepare your submission: bit.ly/4cF0WUW

042

Reposted by Cris Bergerot, PhD

JCO Journals @jco-asco.bsky.social · 23/04/2026

Cancer risk isn’t just about age. A study of 450K people shows lifetime risk varies by up to 2x between individuals. Age-only screening misses high-risk patients and overtests low-risk ones. The future? Personalized, risk-based screening. Read the full article: bit.ly/4dYankA

011

Reposted by Cris Bergerot, PhD

Dr Joseph McCollom DO @realbowtiedoc.bsky.social · 24/04/2026

Our FINAL #webinar for the year 😢 before #ASCO26. Join us for the amazing #DrDale and @mycarg.bsky.social cross over #pallonc #supponc #gerionc

032

Reposted by Cris Bergerot, PhD

American Society of Clinical Oncology @ascocancer.bsky.social · 24/04/2026

🎉Thank you to our dedicated volunteers! Together we connected with lawmakers & advocated for cancer care and research priorities during the 2026 #ASCOAdvocacySummit and Week of Action. Learn more: bit.ly/4vOEbX8

042

Reposted by Cris Bergerot, PhD

ASCO Palliative Oncology Community of Practice (PallOncCoP) @pallonccop.bsky.social · 24/04/2026

We are so excited for our April meeting in collaboration with @mycarg.bsky.social and #GeriOncCoP with guest speaker #DrDale Please DM for the link or to be added to the mailing list. @crisbergerot.bsky.social @realbowtiedoc.bsky.social @tingtingzhang.bsky.social @fionnualacrowley.bsky.social

143

Reposted by Cris Bergerot, PhD

Emil Lou, MD, PhD, FACP, FASCO @cancerassassin1.bsky.social · 19/04/2026

Very happy to be here at #AACR26 with our outstanding @theaacr.bsky.social AACR Scientist↔️Survivor Program partner advocates. 47 patient advocates on site from around the world, selected from over 400 (!) applications.

031

Reposted by Cris Bergerot, PhD

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 20/04/2026

In DC for @ascocancer.bsky.social Advocacy Summit. Excited to speak to our elected officials about key issues directly impacting people with cancer in the US. But first... dinner with 2 incredible cancer leaders whose work spearheaded new spheres of research & advocacy. @drrobinyabroff.bsky.social

071

Reposted by Cris Bergerot, PhD

American Society of Clinical Oncology @ascocancer.bsky.social · 15/04/2026

In our social media coverage of #ASCO26, who do you want to hear from? 1️⃣ Abstract authors 2️⃣ ASCO leadership 3️⃣ Attendees 4️⃣ Presenters and speakers 📊 Show results

032